Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Pemetrexed in Hormone Refractory Prostate Cancer
NCT01338792Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Jun 2006
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, pemetrexed in prostate cancer (PCa), sponsored by University of Southern California. Started Jun 2006; status: completed.
02
Drugs
oxaliplatinpemetrexed
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01338792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01338792.